In a subset of pediatric glioma samples, IHC analysis demonstrated a trend of higher CD45+, CD8+, and PD1+ cells in low-grade gliomas relative to high-grade tumors, showing a more immunosuppressive TME in low-grade tumors. The gene discussed is CD8A; the disease is central nervous system cancer.